Summary

On-body Drug Delivery Devices Market – Scope of Report
TMR’s report on the global on-body drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global on-body drug delivery devices market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global on-body drug delivery devices market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the on-body drug delivery devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global on-body drug delivery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global on-body drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global on-body drug delivery devices market.

The report delves into the competitive landscape of the global on-body drug delivery devices market. Key players operating in the global on-body drug delivery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global on-body drug delivery devices market profiled in this report.

Key Questions Answered in Global on-body drug delivery devices Market Report
• What is the sales/revenue generated by on-body drug delivery devices across all regions during the forecast period?
• What are the opportunities in the global on-body drug delivery devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

On-body Drug Delivery Devices Market – Research Objectives and Research Approach
The comprehensive report on the global on-body drug delivery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global on-body drug delivery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global on-body drug delivery devices market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: On-body Drug Delivery Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. On-body Drug Delivery Devices Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global On-body Drug Delivery Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Wearable Injectors
6.3.2. Auto-injectors
6.3.3. Patches
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global On-body Drug Delivery Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Cardiovascular Diseases
7.3.2. Cancer
7.3.3. Autoimmune Diseases
7.3.4. Diabetes
7.3.5. Others (Orthopedic Disorders, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global On-body Drug Delivery Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Specialty Clinics
8.3.3. Ambulatory Surgery Centers
8.3.4. Others (Research Institutes, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global On-body Drug Delivery Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America On-body Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2020-2034
10.3.1. Wearable Injectors
10.3.2. Auto-injectors
10.3.3. Patches
10.3.4. Others
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Cardiovascular Diseases
10.4.2. Cancer
10.4.3. Autoimmune Diseases
10.4.4. Diabetes
10.4.5. Others (Orthopedic Disorders, etc.)
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Specialty Clinics
10.5.3. Ambulatory Surgery Centers
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe On-body Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2020-2034
11.3.1. Wearable Injectors
11.3.2. Auto-injectors
11.3.3. Patches
11.3.4. Others
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Cardiovascular Diseases
11.4.2. Cancer
11.4.3. Autoimmune Diseases
11.4.4. Diabetes
11.4.5. Others (Orthopedic Disorders, etc.)
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Specialty Clinics
11.5.3. Ambulatory Surgery Centers
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific On-body Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2020-2034
12.3.1. Wearable Injectors
12.3.2. Auto-injectors
12.3.3. Patches
12.3.4. Others
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Cardiovascular Diseases
12.4.2. Cancer
12.4.3. Autoimmune Diseases
12.4.4. Diabetes
12.4.5. Others (Orthopedic Disorders, etc.)
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Specialty Clinics
12.5.3. Ambulatory Surgery Centers
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America On-body Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2020-2034
13.3.1. Wearable Injectors
13.3.2. Auto-injectors
13.3.3. Patches
13.3.4. Others
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Cardiovascular Diseases
13.4.2. Cancer
13.4.3. Autoimmune Diseases
13.4.4. Diabetes
13.4.5. Others (Orthopedic Disorders, etc.)
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Specialty Clinics
13.5.3. Ambulatory Surgery Centers
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa On-body Drug Delivery Devices Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2020-2034
14.3.1. Wearable Injectors
14.3.2. Auto-injectors
14.3.3. Patches
14.3.4. Others
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Cardiovascular Diseases
14.4.2. Cancer
14.4.3. Autoimmune Diseases
14.4.4. Diabetes
14.4.5. Others (Orthopedic Disorders, etc.)
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Specialty Clinics
14.5.3. Ambulatory Surgery Centers
14.5.4. Market Value Forecast, by Country/Sub-region, 2020-2034
14.5.5. GCC Countries
14.5.6. South Africa
14.5.7. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Enable Injections, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. NOVO Engineering
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Elcam Medical
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Battelle
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Gerresheimer AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview